In 2008, the overall scale of Top 100 enterprises in Chinese pharmaceutical industry saw obvious improvement. The aggregate sales was RMB 246.937 billion, rising by over 20% YOY. The market concentration of Top 100 enterprises reached 36.43% YOY in 2008, slightly higher than that of the previous year.
As to the enterprise scale, in 2008, the bottom line of the Top 100 in Chinese pharmaceutical industry exceeded RMB 890 million, rising by 36.92% YOY. In 2008, the bottom scales for Top 50, Top 20 and Top 10 were RMB 1.7 billion, RMB 3.3 billion and RMB 4.2 billion separately. As to the sales scale, in 2008, there were 53 enterprises with the sales scale of RMB 1 billion~2 billion and 30 enterprises with the sales scale of RMB 2 billion ~ 5 billion among the Top 100, increasing by 11 and 9 respectively compared with that of 2007.
Through this report, readers can acquire more information:
-Operation of Chinese pharmaceutical industry, 2008-2009
-Major enterprises and their contact details in Chinese pharmaceutical industry, 2008-2009
Following persons are recommended to buy this report:
- Pharmaceutical manufacturers
- Pharmaceutical traders
-Investors concerning Chinese pharmaceutical industry
-Research institutes concerning Chinese pharmaceutical industry
-Others concerning Chinese pharmaceutical industry
More information can be browsed:
http://www.shcri.com/
Contacts:
Eileen Gu
Sales Manager
China Research and Intelligence
www.shcri.com
Email: eileen@shcri.com
TEL: 86-21-6852-1029 ext.601
86-21-6150-9706
FAX: 86-21-6852-1029 ext.604
# # #
The primary and secondary research was conducted by consultants in China who know the industry and the local markets well.




